Delivery Order SPE2DB20D2104-SPE2DB23FT29V
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,309.01 firm fixed-price contract is for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product. The contract has a completion date of June 7, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor, for the delivery of DIFLUPREDNATE 0.05% EYE DROP 5ML. The $2,877.51 firm fixed-price delivery order has a completion date of March 10, 2023 and was awarded on March 9, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Difluprednate 0.05% eye drops. The $1,143.36 award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,114.56, is a Delivery Order issued by the Defense Logistics Agency (DLA) for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML. The contract has an ultimate completion date of January 13, 2025 and uses a Firm Fixed Price pricing type. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
- This award from the Defense Logistics Agency (DLA) is a delivery order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of Difluprednate 0.05% eye drops in 5 mL packaging, with a ceiling value of $2,286.72 and a performance period through February 23, 2023. This contract does not have a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Difluprednate 0.05% eye drops in 5mL volumes. The $1,171.84 contract has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML. The contract has a ceiling value of $1,241.12 and is a firm fixed price arrangement. It is funded by the Defense Logistics Agency (DLA), a defense agency that provides worldwide logistics support. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,807.19 firm fixed price delivery order is for the provision of Difluprednate 0.05% eye drops, 5 ml. The contract has a completion date of February 28, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,628.46, is for the delivery of DIFLUPREDNATE 0.05% EYE DROP 5ML, a prescription eye medication. The contract is a delivery order with a firm fixed price, and the ultimate completion date is December 13, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product, with a ceiling value of $14,663.65. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, which has a maximum value of $999,999,999.00 and runs through...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FT29VDelivery Order
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of DIFLUPREDNATE 0.05% eye drops. The $1,549.50 contract has a completion date of May 2, 2023 and does not have a set-aside designation, indicating full and open competition. AmerisourceBergen Drug Corporation is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 5/1/23 |